More answers like this
GPT-5Sep 11, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Leans yes
Short answer: not a blanket pause, but targeted restrictions and the ability to order time‑bound pauses when concrete risk thresholds are met.
Why not a blanket pause?
•Benefits are real and time‑sensitive (healthcare, education, accessibility, science).
•Pausing everything would also pause safety research and push development to less accountable actors.
•Enforcement and international coordination for a global halt are impractical.
What should be restricted now?
•High‑risk uses and deployments (biological design assistance, exploit generation, model‑driven market manipulation, critical infrastructure control).
•Access to large amounts of cutting‑edge compute for training frontier models without a license and safety plan.
•Release of model weights when evals show strong dual‑use capabilities; use staged/partial releases instead.
When should we consider a pause?
•If evaluations show a model can enable novices to create or significantly enhance biological, chemical, nuclear, or large‑scale cyber harm.
•If red‑teaming reveals autonomous replication/persistence, strategic deception, or uncontrollable model behavior.
•If incident rates in the wild exceed agreed safety thresholds and mitigations are not yet available.
Such pauses should be time‑boxed, tied to specific remediation goals, and independently verified before resumption.
Practical policy package (balanced approach)
•Tiered risk framework: lighter rules for low‑risk systems; strict pre‑deployment testing, audits, and post‑deployment monitoring for frontier models.
•Licensing for frontier model training and deployment, tied to:
•Independent evaluations and red‑teaming against bio/cyber/misinformation/autonomy risks.
•Proven safety mitigations (guardrails, rate limits, fine‑tuning controls, content provenance/watermarking where feasible).
•Incident reporting, recall/kill‑switch capability, and post‑mortems.
•Compute and data governance: track large training runs; require documentation of data sources, privacy/IP compliance, and dataset risk assessments.
•Release governance: staged access, safety‑tuned variants for high‑risk capabilities, and delayed weight releases when dual‑use risk is high.
•Sector rules: apply domain regulations (e.g., medical, finance, aviation) to AI systems used there, with liability that aligns incentives.
•International coordination: common test suites, audit standards, and channels for rapid risk/incident sharing; export and procurement policies that reinforce safety.
•Support the good stuff: open safety research, interpretability, evaluations, robustness, and alignment; funding and compute credits for safety‑critical work.
If you’re asking for your organization: I can help turn this into a concrete policy with thresholds, evals, deployment gates, and an incident response plan. If you’re asking from a public‑policy angle: tell me your priorities (innovation, national security, consumer protection, competition), and I’ll tailor a model bill or regulatory brief.